Perspectives
Nature Reviews Cancer 6, 146-155 (February 2006) | doi:10.1038/nrc1804
Focus on: Biomarkers
Innovation: Mapping normal and cancer cell signalling networks: towards single-cell proteomics
Jonathan M. Irish1, Nikesh Kotecha2 & Garry P. Nolan3 About the authors
Abstract
Oncogenesis and tumour progression are supported by alterations in cell signalling. Using flow cytometry, it is now possible to track and analyse signalling events in individual cancer cells. Data from this type of analysis can be used to create a network map of signalling in each cell and to link specific signalling profiles with clinical outcomes. This form of 'single-cell proteomics' can identify pathways that are activated in therapy-resistant cells and can provide biomarkers for cancer diagnosis and for determining patient prognosis.
Author affiliations
- Jonathan M. Irish is at the Department of Medicine, Oncology Division, Stanford University, Stanford, California 94305, USA.
- Nikesh Kotecha is at the Department of Biomedical Informatics, Stanford University, Stanford, California 94305, USA.
- Garry P. Nolan is at the Baxter Laboratory for Genetic Pharmacology, Department of Microbiology and Immunology, Stanford University, Stanford, California 94305, USA.
Correspondence to: Garry P. Nolan3 Email: gnolan@stanford.edu
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
High-content single-cell drug screening with phosphospecific flow cytometryNature Chemical Biology Article (01 Feb 2008)
